MIRA INFORM REPORT
|
Report No. : |
316033 |
|
Report Date : |
11.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
HIKMA PHARMA ALGERIA SARL |
|
|
|
|
Registered Office : |
Zone D'Activate Staoueli Tranche 16/15 Alger 16101, |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
02.05.2000 |
|
|
|
|
Com. Reg. No.: |
00B0012263 |
|
|
|
|
Legal Form : |
Societe Anonyme
Responsabilitee Limitee |
|
|
|
|
Line of Business : |
Subject operate as manufacturers
and suppliers of pharmaceuticals |
|
|
|
|
No. of Employee : |
80 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 250,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Algeria |
B2 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
ALGERIA ECONOMIC OVERVIEW
Algeria's economy remains dominated by the state, a legacy
of the country's socialist postindependence development model. In recent years
the Algerian Government has halted the privatization of state-owned industries
and imposed restrictions on imports and foreign involvement in its economy.
Hydrocarbons have long been the backbone of the economy, accounting for roughly
60% of budget revenues, 30% of GDP, and over 95% of export earnings. Algeria
has the 10th-largest reserves of natural gas in the world and is the
sixth-largest gas exporter. It ranks 16th in oil reserves. Strong revenues from
hydrocarbon exports have brought Algeria relative macroeconomic stability, with
foreign currency reserves approaching $200 billion and a large budget
stabilization fund available for tapping. In addition, Algeria's external debt
is extremely low at about 2% of GDP. However, Algeria has struggled to develop
non-hydrocarbon industries because of heavy regulation and an emphasis on
state-driven growth. The government's efforts have done little to reduce high
youth unemployment rates or to address housing shortages. A wave of economic
protests in February and March 2011 prompted the Algerian Government to offer
more than $23 billion in public grants and retroactive salary and benefit
increases, moves which continue to weigh on public FINANCES
.
Long-term economic challenges include diversifying the economy away from its
reliance on hydrocarbon exports, bolstering the private sector, attracting
foreign investment, and providing adequate jobs for younger Algerians.
|
Source
: CIA |
Company
NAME
|
|||
|
Registered Name: |
HIKMA PHARMA
ALGERIA SARL |
||
|
Requested Name: |
HIKMA PHARMA ALGERIA |
||
|
Other Names: |
None |
||
ADDRESS
AND TELECOMMUNICATION
|
|||
|
Physical Address: |
Zone
D'Activate Staoueli Tranche 16/15 |
||
|
|
Alger 16101, |
||
|
Country: |
Algeria |
||
|
Phone: |
213-23209100/1/2/3/4 |
||
|
Cell: |
213-561654608/619597/8/617812/13/14/15/16 |
||
|
Fax: |
213-23209112 |
||
|
Email: |
|||
|
Website: |
www.hikma.com |
||
CREDIT
OPINION
|
|||
|
Financial Index as of
December 2014 shows subject firm with a medium risk of credit. However, bank
and credit information obtained reveal a history of prompt payments. We
recommend Credit of USD 250,000 on 90 days. |
|||
LEGAL
|
|||
|
Legal Form: |
Societe Anonyme
Responsabilitee Limitee |
||
|
Date Incorporated: |
02-May-2000 |
||
|
Reg. Number: |
00B0012263 |
||
|
Nominal Capital |
DZD.
62,583,000 |
||
|
Subscribed Capital |
DZD.
62,583,000 |
||
|
Subscribed Capital is Subscribed in the following form: |
|||
|
|
Position |
Shares |
|
|
Mr. Samih Darwazah |
Group
Chairman |
|
|
|
Mr. Mazen Darwazah |
MD |
|
|
|
Mr. Mohamed Bennabi |
Director |
|
|
|
Hikma Pharmaceuticals Plc UK |
Holding
Co. |
100% |
|
RELATED
COMPANIES
|
|||
|
Hikma Pharmaceuticals Plc UK |
Parent company. |
||
|
None |
Subsidiary company. |
||
|
Various worldwide |
Affiliated companies. |
||
|
None |
Shareholder of subject
firm. |
||
|
None |
Branches of the firm |
||
OPERATIONS
|
|||
|
Registered to operate as manufacturers
and suppliers of pharmaceuticals |
|||
|
Imports: |
Middle East, Europe |
||
|
Exports: |
Neighboring coutnries |
||
|
Trademarks: |
None |
||
|
Terms of sale: |
Cash (40%) and 25-90 days (60%), invoices. |
||
|
|
|
||
|
Main Customers: |
firms and organizations |
||
|
Employees: |
80 employees. |
||
|
Vehicles: |
Several motor vehicles. |
||
|
Territory of sales: |
Algeria |
||
|
Location: |
Leased premises, 100,000 square feet, |
||
AUDITORS
AND INSURANCE
|
|||
|
Auditors: |
Information not available. |
||
|
Insurance Brokers: |
Information not
available. |
||
FINANCE
|
|||
|
Currency Reported: |
Algerian Dinar (DZD.) |
||
|
Approx. Ex. Rate: |
1 US Dollar = 97.26
Algerian Dinar |
||
|
Fiscal Year End: |
December 31, 2014 |
||
|
Inflation: |
According to information given by independent sources, the inflation
at December 31st, 2014 was of 13%. |
||
|
|
|||
|
Group Financial
Information Submitted Below |
|
||
BANK
|
|||
|
Bank Name: |
Banque
de l'Agriculture et du Développement Rural (BADR). |
||
|
Branch: |
Algeria |
||
|
Comments: |
None |
||
TRADE REFERENCES
|
|||
|
Experiences: |
Good |
||
|
|
|
||
|
NOTARIAL BONDS |
None |
||
COMMENTS
/ ADDITIONAL INFORMATION
|
|||
|
This information was obtained
from outside sources other than the subject company itself and confirmed the
above subject. |
|||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.37 |
|
|
1 |
Rs.91.60 |
|
Euro |
1 |
Rs.66.49 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.